PHAXIAM Therapeutics S.A. Sponsored ADR Operating Income 2020-2023 | PHXM

PHAXIAM Therapeutics S.A. Sponsored ADR operating income from 2020 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
PHAXIAM Therapeutics S.A. Sponsored ADR Annual Operating Income
(Millions of US $)
2022 $-3
2021 $-67
2020 $-79
2019 $-78
2018 $-57
2017 $-39
2016 $-29
PHAXIAM Therapeutics S.A. Sponsored ADR Quarterly Operating Income
(Millions of US $)
2023-06-30
2019-09-30 $-18